medigraphic.com
ISSN 1029-3035 (Electronic)

2011, Number S2

<< Back Next >>

Mediciego 2011; 17 (S2)

Hemodynamic behaviour of total intravenous anaesthesia with propofol in surgery of intracranial tumours

Pérez PN, Fernández LE, Regueiro USD, Ortega HP

Language: Spanish
References: 27
Page:
PDF size: 55.51 Kb.


ABSTRACT

Introduction: Within the neurosurgical conditions, brain tumors conform a very peculiar group and constitute a challenge for the anesthesiologist. Objectives: To specify the anesthetic conduct in patients with supratentorial intracranial tumors and the perioperative behavior of hemodynamic variables, perioperative complications as well as to correlate the complications appeared with the age of patients. Method: A descriptive study was carried out, with 39 patients underwent surgery of supratentorial intracranial tumors, in “Capitán Roberto Rodriguez Fernandez” Hospital, Morón, between January 2009 and December 2010. Total intravenous anesthesia with Propofol was applied to them. All of them greater than 18 years, with physical state ASA II, III and Glasgow scale superior to 8 points. The induction and maintenance were made with propofol, fentanyl and vecuronium, oxygen and compressed air. The bio-parameter behavior was monitoring in four times. Results: It was found stability in the monitorized parameters. The most frequent complication was the respiratory alkalosis. Complications related to propofol were not identified, nor correlation between complications appeared and the age of the patients.


REFERENCES

  1. Sastre SL. Anestesia. En: Sastre SL. Neuroanestesia. La Habana: Editorial Científico-Técnica; 1980. p. 15-6.

  2. Kamal T. Tumores intracraneales. En: Organización Panamericana de la Salud, editor. Oncología clínica. Washington: OPS; 1999. p. 424-450.

  3. Shapiro HM, Drummond JC. Neurosurgical anestesia and intracraneal hypertension. En: Miller. Anestesia. 5 ed. Nueva York: Churchill Livingstone; 2002. p. 243-5.

  4. Reivich M. Regulation of the cerebral circulation. Clin Neurosurg. 2008; 1:378-85.

  5. Sepúlveda P. Pasado, presente y futuro de la anestesia total intravenosa [Internet]. 2002 [citado 11 Feb 2010] [aprox. 6 pantallas]. Disponible en: http://www.AstraZeneca Cl/revista/2002-4/pasado-presente-futuro.cup

  6. Vuyk J. Infusión controlada por ordenador. En: Engbers MP. Coloquios anestesiológicos. Madrid: Medicine Group; 2009. p. 4-6.

  7. Baden JM. Agentes inhalatorios, metabolismo y toxicidad. En: Miller RD. Anestesia. 2 ed. San Francisco: Doyma; 2007. p. 132-4.

  8. Dershwits M. Intravenous and inhalation anesthetics. En: Hurford WE, Bailin MT, Bailin JK, Hospel KL, Vassallo SA. Clinical anesthesia procedures of the Massachusetts general hospital. 6 ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 156-8, 162-5.

  9. Dundee J, Wyantg E. Aplicación clínica de la anestesia intravenosa. En: Anestesia intravenosa. Barcelona: Salvat; 1979. p. 18-31.

  10. Rodríguez VM, Sainz CH. Historia de la anestesia. En: Dávila Cabo de Villa E, Gómez Brito C, Álvarez Bárzaga M, Sainz Cabrera H, Molina Louis RM. Anestesiología Clínica. Cienfuegos: Ediciones Damují; 2001. p. 43-7.

  11. Amerein R, Metzel W. Pharmacology of propofol and anexate. Acta Anestesiol Scand. 2009; 34(4): 6-115.

  12. Cuba. Ministerio de Salud Pública. Anestésicos generales. En: Formulario nacional de medicamentos. La Habana: Editorial Ciencias Médicas; 2006. p. 523-532.

  13. Navarrette VM. Anestesa inravenosa. Elementos de farmacocinética. En: Dávila Cabo de Villa E, Gómez Brito C, Rodríguez Varela M, Sainz Cabrera H, M Álvarez Bárzaga, H Sainz Cabrera, et al. Anestesiología Clínica. Cienfuegos: Ediciones Damují; 2001. p. 126-32.

  14. Dennis S, Charney, JM. Hipnóticos y sedantes. En: Goodman Gilman A. Las bases farmacológicas de la terapéutica. 10 ed. Mexico: McGraw Hill; 2201. p. 407-421.

  15. Propofol [Internet]. 2008 [citado 7 Abr 2010] [aprox. 4 pantallas]. Disponible en: http://www.Vademecum%20Argentina%20-%20medicamentos%20-20Propofol.htm

  16. Reves JG, Glass P, Labarsky DA. Non barbitutate intravenous anaesthetics. En: Miller R. Anaesthesia. 5 ed. New York: Churchill Livingstone; 2000. p. 398-9.

  17. Gold E, Christensen KJS, Nortdentof V, Engberg V, Perdersen B. Cerebral blood flow metabolic rate of oxigen and relative CO2 reactivity in patient subjected to craniotomy for supratentorial cerebral tumors. Acta Anaesthesiol Scand. 2009; 31: 310-15.

  18. Del Pino JJ, Solis HD. Propofol en neuroanestesia. Invest Med Quirúrg. 2009; 3(1): 27-31.

  19. Coles JP, Leary TS, Monteiro JN. Propofol anesthesia for craniotomy: a double–blind comparison of remifentanil, alfentanil and fentanyl. J Neurosurg Anesth. 2008: 12: 15-22.

  20. Paulo E, Archiva F, Pedro E. Dormicum. En: Diccionario de especialidades farmacéuticas. Colombia: PLM: 2009. p. 502-4.

  21. Fith W, Mackenzie T, Harper AM. Effects of decreasing arterial blood pressure on cerebral blood flow. Circ Res. 2003; 37: 550-7.

  22. Bill A, Linder J, Linder M. Sympathetic effect on cerebral blood vesseles in acute arterial hypertesion. Acta Physiol Scand. 2008; 96: 114-21.

  23. William D, Sefton MD. Hipertensión intracraneal. En: Secretos de la anestesia. Nueva York: Rosemberg; 2009: 377-82.

  24. Michelfelder JD. Anesthesia and brain. En: Miller. Anestesia. Nueva York: Churchill Livingstone; 2005. p. 444-46.

  25. Reivich M. Regulation of the cerebral circulation. Clin Neurosurg. 2007; 1: 378-85.

  26. Suárez MM, Mendoza P. Tasas de infusión e influencia de la edad. Rev Mex Anest. 1999; 22(1): 7-9.

  27. Stanley M. Anestesia en el anciano. En: Miller. Anestesia. 5 ed. Nueva York: Churchill Livingstone; 2002. p. 1805-7.




2020     |     www.medigraphic.com